chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient began to have excruciating pain left shoulder with low range of motion. following injection.  Temp 100.4 with pain that comes and goes over the course of the following week.
I woke up with ringing in my ears the next morning 4/23.  It has been constant and has not gone away.  I also have ear pain that has started from the constant ringing.  My ears have been ringing for 5 days now.  I am starting to get very concerned as I have not had this problem before. I am wondering when the ear ringing is going to go away, and why my body has responded this way to my first dose of Covid vaccine.  I had an appointment with my Primary Care Dr. today who is referring me to an ENT now. I wish I could make the ear ringing go away and am concerned as to why the vaccine would give me this side effect.
This spontaneous report was received from a certified medical assistant referring to an unspecified number of unspecified patients of unknown age and gender. Concurrent conditions or pertinent medical history were not reported. The medical assistant reproted that the patients were administered an unspecified number of improperly stored doses of GARDASIL (lot # K006960, expiration date: 19-FEB-2017) (route of administration and frequency were not reported) on unspecified dates since 21-MAY-2015. No adverse effects reported. Concomitant medications were not reported. This is one of two reports from the same source. Additional information has been requested.
Hard, red lump at injection site (2nd dose), itchy. Low grade fever. Achy arm, neck, back.
Information has been received from a licensed practical nurse concerning a 28 month old male with autism who on 06-MAR-2009 was vaccinated with the first dose of VARIVAX (Merck) (lot # 662201/1544X), SQ, 0.5ml. There was no concomitant medication. On 16-MAR-2009 the patient experienced vesicular lesions at the injection site of the left upper arm. The patient was examined in the office on 19-MAR-2009 and was prescribed topical antibiotic ointment. At time of the report the patient was recovering. Follow-up information has been received from a licensed practical nurse concerning the patient on 06-MAR-2009 was vaccinated with first dose of VARIVAX (Merck) (lot # 662201/1544X) in left arm, SQ, 0.5ml. On 16-MAR-2009 the patient's skin at site of vaccine 3 blisters with slight scab and faint erythema of 3 cm. Antibiotic ointment was applied to the area. No further information is available. This is one of several reports received from the same source.
On June 21, 2021 (Four weeks after receiving second Pfizer Covid-19 shot) I developed peripheral neuropathy in my arms , hands, legs, and feet.  The symptoms are severe with burning-jabbing pain that is relentless.  October 1, 2021 started  Electric Cell Signaling Therapy at two days per week until the end of November.  No Improvement so far.
December 1 2021 Vial moved from Freezer to Fridge  January 6, 2022 Vaccine administered.
right knee still swollen; diagnosed with Baker's cyst; A lot of soreness in the arm; Tightness in upper back up to my neck/ tightness in the (right) calf; bad calf cramp; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (A lot of soreness in the arm), MUSCLE TIGHTNESS (Tightness in upper back up to my neck/ tightness in the (right) calf), MUSCLE SPASMS (bad calf cramp), SYNOVIAL CYST (diagnosed with Baker's cyst) and JOINT SWELLING (right knee still swollen) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 042L20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included UBIDECARENONE (COQ 10), COLOSTRUM (COLOSTRUM 6), VITAMIN D NOS, AMOXICILLIN TRIHYDRATE, BROMHEXINE HYDROCHLORIDE (MOX BRO) from an unknown date to 09-Mar-2021 and DOCOSAHEXAENOIC ACID (DHA) for Immune system disorder (NOS).   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced VACCINATION SITE PAIN (A lot of soreness in the arm), MUSCLE TIGHTNESS (Tightness in upper back up to my neck/ tightness in the (right) calf) and MUSCLE SPASMS (bad calf cramp). On 08-Jul-2021, the patient experienced SYNOVIAL CYST (diagnosed with Baker's cyst). On an unknown date, the patient experienced JOINT SWELLING (right knee still swollen). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Muscle tightness, at an unspecified dose and frequency; IBUPROFEN ongoing since an unknown date for Muscle tightness, at an unspecified dose and frequency and CORTISONE on 08-Jul-2021 for Baker's cyst, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (A lot of soreness in the arm) and MUSCLE SPASMS (bad calf cramp) had resolved and MUSCLE TIGHTNESS (Tightness in upper back up to my neck/ tightness in the (right) calf), SYNOVIAL CYST (diagnosed with Baker's cyst) and JOINT SWELLING (right knee still swollen) had not resolved.            TIce pad  treatment on the calf reported. In Jun-2021, patient underwent 3 X-rays, result unknown.   This case was linked to MOD-2021-027570 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Follow-up information will be processed with the initial report. Updated information includes patient demographics, concomitant drugs and event of right knee still swollen. On 26-Jul-2021: Follow-up received on 26-Jul-2021 contained for event diagnosed with Baker's cyst outcome as not recovered (previously captured as unknown). Treatment drug cortisone used for bakers cyst (previously captured as back of the knee).
This case was reported by a pharmacy student and described the occurrence of sore eye in a 23-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). On 24 September 2012 at 16:20 the subject received unspecified dose of BOOSTRIX (unknown). On 24 September 2012, at the time of vaccination with BOOSTRIX, the subject experienced eyes splashed with vaccine. On 24 September 2012, within minutes of vaccination with BOOSTRIX, the subject experienced sore eye and eye irritation. The pharmacy student, who is also the subject, reported there was pressure in the bottle of BOOSTRIX and thinks it sprayed from the bottle into her right eye. The reporter did not consider there to be anything wrong with the BOOSTRIX vial. The subject's right eye was a bit sore and irritated however she said it could be from rinsing it. The reported planned to seek medical attention. At the time of reporting the sore eye and eye irritation were unresolved.
Information has been received from a clinical practice manager concerning a female patient of unknown age. There was no information about concurrent condition, concomitant medication and medical history. On 13-DEC-2016, the patient was vaccinated with a dose of PNEUMOVAX23 (lot # reported as M041811, expiration date 25-MAY-2018) (dose, frequency and route unknown) for prophylaxis. On an unspecified date in December 2016 after vaccinated with PNEUMOVAX23, the patient developed cellulitis, which extended beyond the injection sites. Treatment with unspecified antibiotics was given to the patient. The outcome of the event was unknown. The causality between the event and PNEUMOVAX23 was not provided. Upon internal review, cellulitis was determined to be medically significant. This is one of several reports received from the same reporter. Additional information is not expected as there is no consent for follow-up.  Sender's Comments: US-009507513-1612USA009590: US-009507513-1612USA012869.
Red rash; Pain on top of arm to the elbow/arm hurt; Tired; Rash; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain on top of arm to the elbow/arm hurt), FATIGUE (Tired), RASH (Rash) and RASH ERYTHEMATOUS (Red rash) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain on top of arm to the elbow/arm hurt), FATIGUE (Tired) and RASH (Rash). On 19-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Red rash). At the time of the report, PAIN IN EXTREMITY (Pain on top of arm to the elbow/arm hurt), FATIGUE (Tired) and RASH (Rash) was resolving and RASH ERYTHEMATOUS (Red rash) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. Treatment included Cortisone cream to treat her symptoms.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: No new information.
The injection site is 5 degrees warmer than the rest of the arm, and still sore to the touch. Slightly pinker to the rest of the arm, also the rest of the arm is colder as well than a normal arm. Normally is not noticable unless touched, hence was not noticed for two weeks.
Shortness of breath. Stridor, could not breath. Swelling around both eyes.
Rcvd first COVID shot in Left deltoid on 12/27. After shot, arm very sore, and progressed over the last 8 weeks to reduced ROM, weakness, pain, and intermittent numbness. Contacted employee health and their MD stated the following:   "Here is the information I received from, the Director of Infectious Diseases .  She suggested that you follow up with your pcp to start.  The syndrome is called Parsonage-Turner.   Management and prognosis ? There is no specific treatment for neuralgic amyotrophy. Management is conservative. Physical therapy may be helpful to preserve range of motion but will not hasten recovery. Glucocorticoids have been advocated by some [34], but no clinical studies have demonstrated efficacy. In the first weeks, analgesic drugs, including narcotics, may be required to manage patients with severe pain.  Recovery occurs slowly over one to three years, and some patients have persistent disability."  I have contacted my PCP who has ordered a PT consult (scheduling next week), also seeing an acupuncturist for treatment.
After injection pt was escorted by RN to observation area. In route, patient passed out. Color became dusky. Spo2 was 88-100 %. Dr ordered Epi Pen to be administered to left thigh at 1258. EMS was notified and patient taken to Hospital. Upon arrival to ED pt reports she became suddenly dizzy then woke up in the ED. She experienced chest tightness, sore throat, tongue swelling. Second epi was given in the ED. Developed muscle stiffness in the ED.
Day 1, sore arm.  Day 2 chills, fever to 101.4.  Day 3 OK, Day 4 lethargy, Day 5 chills, fever to 102.0, diarrhea, sore joints
Patient called today 1/6/14 stating he started experiencing tingling and numbness in right hand sometime between 11/4/13 when he received immunization and 11/23/13. Since then it has also moved to other hand both wrists and shoulder. Saw family MD 11/23/13 - also saw pain doctor who referred to neurologist: none could diagnose unsure of dates.
2 Days after injection, developed extreme inflammation in all joints. Could barely get out of bed. By the 3rd day I was almost crippled.  Had to find an endocrine doctor and was placed on prednisone for 10 months till the markers came down. Since tapering off the prednisone, I have been much better, and markers have been down consistently. I am a perfectly healthy 65 year old man who is extremely active, and still works.
This spontaneous case reported by a pharmacist, describes the occurrence of COVID-19 in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced COVID-19. At the time of the report, COVID-19 outcome: unknown. Diagnostic results: On an unknown date, COVID-19: positive. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. The reporter did not provide any causality assessments, concomitant medications or treatment information. Most recent follow-up information incorporated above includes: On Jul 8, 2021: Follow-up received. No significant information updated.
Case number PHEH2014US020230 is an initial spontaneous report from a health care professional (allergy technician) received on 08 OCT 2014. This report refers to a female patient whose age was not reported. Her medical history and concomitant medication were not provided. It was reported that on 03 OCT 2014, she received a dose of expired FLUVIRIN (batch number: unknown) intramuscularly on 03 OCT 2014. No adverse events were reported following maladministration.
Injection around 9:25am. She became dizzy at 9:30am in the chair in the waiting area after vaccine. Juice provided as well as water. @9:30 her BP was 120/88 Pulse 70. Pt talking. Felt slightly better after juice- still a bit shaky and dizzy. At 9:56 am she still was not feeling right- stating head heavy and now her chest had a tightness in the center- still Alert and oriented. BP recheck was 160/96 in left and 160/100 in right with a pulse of 88. 911 was called at this time. Ambulance arrived and patient went to the ER at 10:15am
Patient is experiencing every side effect; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Patient is experiencing every side effect) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Patient is experiencing every side effect). At the time of the report, ADVERSE EVENT (Patient is experiencing every side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.
Seriousness criteria other medically significant (OMIC). Initial report received on 4/19/2006 from a physician. A 13 year old female patient with no reported illnesses, pre existing medical conditions, or use of other medications, had received an administration of Menactra, lot number U2003AA, in the right deltoid, and an administration of Decavac, lot number U1619BA, in the left deltoid in 4/11/2006. The route of administration was not reported for either vaccine. 24 hours post immunization, the patient experienced severe pain in her arms bilaterally, generalized aches, bilateral leg weakness, and shakiness. She was taken to the ER where laboratory data was collected, and the results were within normal limits. She was released the same day. The patient was seen by her physician on 4/19/2006 and at that time, she was still shaky when walking, and continued with generalized weakness that was accompanied by absent bilateral ankle/plantar reflexes. Per the reporter, no foot drop was present. The patient had not recovered from these events at the time of this report.
Information has been received from a medical assistant concerning a 60 year old female patient with asthma, gastrooesophageal reflux disease, hypertension, arthritis, cardiac failure congestive, pulmonary embolism and rhinitis allergic and no drug reactions/allergies, who on 26-OCT-2010 was vaccinated with a dose of PNEUMOVAX 23 (Lot # 665925/0932Z Exp 18-JUL-2011). Concomitant therapy included warfarin, SINGULAIR, SYMBICORT, PREVACID, prednisone, potassium (unspecified), NASONEX, NAPROSYN, lisinopril, DARVOCET-N, calcium (unspecified), ALLEGRA-D, albuterol sulfate and albuterol sulfate. On 26-OCT-2010, at night, the patient began to develop redness, swelling, and heat at the injection site. She also had a fever. She was diagnosed with cellulitis. She received CIPRO. She recovered on 04-NOV-2010. This is one of several reports from the same source. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available. A standard lot check investigation has been finalized. All in-process quality checks for the lot number 665925/0932Z were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Follow-up information was received from a medical assistant who stated that the patient with no illness at time of vaccination "healthy", on 26-OCT-2010, was vaccinated IM in the right arm with a dose of PNEUMOVAX 23 (Lot# 665925/0932Z) at 14:30. It was reported also that on 26-OCT-2010 (also reported as 28-OCT-2010) at 12:45, the patient complaint of redness, pain, swelling at injection site, within 8-10 hours. The patient was seen in the office on 28-OCT-2010 for the same reason. Patient was given Ciprofloxacine 750 mg for 7 days. And on 01-NOV-2010 (previously reported as 04-NOV-2010), the condition resolved and patient recovered. The reporting physician considered cellulitis an other important medical event. No further information is available.
Woke up and my hands were both itchy, and my right hand hurt along the top of the palm, where the knuckles are. Itching has persisted in both hands for 12 hours, but has been far worse on right. Also have a round patch of itchy skin on right wrist two inches long by one inch wide (roughly). If I squeeze the fingers of my right hand into a fist, I feel significant pain up my fingers starting at the knuckles on the palm-side of my hand. I have the same reaction on my left hand, but far less.   My hands have been dry recently due to frequent washing, so I originally attested the itching, pain and redness to that, but when it didn't fade like it normally does when I applied lotion, I became a little concerned. I took an allergy pill (Loratadine - Generic) and it reduced the symptoms a bit, but the pain and itching are still very present.
Arm soreness, itchiness directly following injection and continuing to a lesser degree to this day, nearly 3 months later.
11/16/02 Complained of edema and redness at site; slight yellow discharge from site where vaccine given; describes as if pimple burst. Applied warm compresses. Notified physician and seen on 11/18/02. Was told area was slightly infected. No antibiotics given. Rx warm compresses and observe.
One day after vaccine my eye felt slightly irritated. The next day I felt a little swelling in the corner of my left eye on the same side of vaccine. It became visible as an irritation on the outside corner of my eye. It was very painful and my lower eyelid was swollen. I was trying to massage but the pain seemed to be internal. There was a large red pimple like lesion inside my eyelid. I went to an eye doctor and was diagnosed with an internal sty on my eye. I have never had a Sty before. I was prescribed an antibiotic and it not not resolve so I was prescribed a antibiotic cream which helped. The lesion burst by then. I took two to three weeks to resolve. I since also received the second dose. I had a very strong immune response to the second dose. Chills, headaches and all over body ache. I was unable to work for two days. I was bed ridden for two days. My Asthma seemed very reactive during that time. My Asthma seemed worse for a few weeks and it is still a little worse than normal.
This spontaneous report was received from a pharmacist refers to patient of unknown age and gender. The patient's concurrent conditions, medical history and drug reactions and allergies was unknown. The patient's concomitant therapy included sterile diluent. On 27-JUL-2017, the patient was vaccinated with one dose of improperly stored ZOSTAVAX (units and frequency were unknown) (Lot # M040146 and expiration date 26-DEC-2017) for prophylaxis. Reporter informed that, there was temperature excursions for the ZOSTAVAX (Lot # M040146 and expiration date 26-DEC-2017) at a temperature of 15°F to 46°F and time frame 14 hours 30 minutes. There was no previous temperature excursion. The call was because of a data logger. No adverse effects were reported. There was no product quality compliant reported.
I woke up in the middle of the night with itching. I took an antihistamine. That helped but when it wore off the itching came back and its been persistent. It caused hives around my bellybutton, shoulders, back and chest. It does affect my arms and legs, but not as prominent. It definitely seems like an allergic reaction, but I don't know the cause. I have eliminated foods that could cause it. I even changed my laundry detergent and nothing is changing it. I think it is a reaction to the shingles vaccine and Pfizer booster being taken in close timing. On 03/06/2022, I did see my doctor. He advised to keep taking the antihistamines. On 03/10/2022, I was prescribed a topical cream for the hives. I now take antihistamines three times a day and it helps, but if I don't take it on time the itching starts all over.
2nd Moderna Vaccine given > 42 days past 1st Vaccine; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd Moderna Vaccine given > 42 days past 1st Vaccine) in a 55-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd Moderna Vaccine given > 42 days past 1st Vaccine). On 22-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd Moderna Vaccine given > 42 days past 1st Vaccine) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided No treatment medication information was provided
Significant swelling at inject site-L tricep, redness, soreness lasting 1 wk. Told to take Tylenol for pain.
Red, painful flat  rash, upper arm  anterior to injection site. Severe anterior upper arm pain
01/30/08 730AM vomiting x1, fever 100.5, headache, chills - No treatment; 1030 AM "feels little better"; 1200AM "vomited x4 and still has headache"; was not feeling well before shot on 1-28. 01/31/08- no nausea and vomiting - still has chills, chest congestion - MD appt. 2/16/08; 2/18/08 received call back from client - evaluated by me on 2/1/08 "flu or view" "not related to shot(Tdap)/ I'm back to full health" RN
Fever of 102.5 one hour after the  DTaP1/Hib/IVP  shot administered.  Also signs of severe distress, screaming and crying. He continually grasped my shirt. I immediatley reported it to the doctor, and gave him motrin for the fever. Symptoms subsided. However I felt suspicious something worse happened. No one could give me a medical/scientific explaination.
Stomachache started on 1/13/21 and lasted for 5 days.  Headache started on 1/14/21 and lasted 2 days.  1/15/21 diarrhea for 2 days.  1/16/21 chills, fever, body and joint aches.  Severe fatigue started on 1/14/21 and lasted for 5 days.